John D. Ulm

Array ( [id] => 4404410 [patent_doc_number] => 06171803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Isolation, characterization, and use of the human .beta. subunit of the high affinity receptor for immunoglobulin E' [patent_app_type] => 1 [patent_app_number] => 9/103663 [patent_app_country] => US [patent_app_date] => 1998-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 61 [patent_no_of_words] => 20581 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171803.pdf [firstpage_image] =>[orig_patent_app_number] => 103663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495345 [patent_doc_number] => 06403552 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Ob receptor and methods for the diagnosis and treatment of body weight disorders' [patent_app_type] => B1 [patent_app_number] => 09/094410 [patent_app_country] => US [patent_app_date] => 1998-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 40 [patent_no_of_words] => 60814 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403552.pdf [firstpage_image] =>[orig_patent_app_number] => 09094410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240252 [patent_doc_number] => 06166181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Human adenosine receptors' [patent_app_type] => 1 [patent_app_number] => 9/080704 [patent_app_country] => US [patent_app_date] => 1998-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 13534 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166181.pdf [firstpage_image] =>[orig_patent_app_number] => 080704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565160 [patent_doc_number] => 06376198 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Assay for non-peptide agonists to peptide hormone receptors' [patent_app_type] => B1 [patent_app_number] => 09/076510 [patent_app_country] => US [patent_app_date] => 1998-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 14159 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376198.pdf [firstpage_image] =>[orig_patent_app_number] => 09076510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4366523 [patent_doc_number] => 06287782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Methods of using the Ob receptor to identify therapeutic compounds' [patent_app_type] => 1 [patent_app_number] => 9/069781 [patent_app_country] => US [patent_app_date] => 1998-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 40 [patent_no_of_words] => 64269 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287782.pdf [firstpage_image] =>[orig_patent_app_number] => 069781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4256357 [patent_doc_number] => 06203998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Human dopamine receptor and its uses' [patent_app_type] => 1 [patent_app_number] => 9/060694 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 9308 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/203/06203998.pdf [firstpage_image] =>[orig_patent_app_number] => 060694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4221382 [patent_doc_number] => 06010886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Receptor for oncostatin M' [patent_app_type] => 1 [patent_app_number] => 9/058264 [patent_app_country] => US [patent_app_date] => 1998-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22790 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010886.pdf [firstpage_image] =>[orig_patent_app_number] => 058264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4357790 [patent_doc_number] => 06168927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Expression of G protein coupled receptors in yeast' [patent_app_type] => 1 [patent_app_number] => 9/056920 [patent_app_country] => US [patent_app_date] => 1998-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5239 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/168/06168927.pdf [firstpage_image] =>[orig_patent_app_number] => 056920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4218950 [patent_doc_number] => 06111075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Protese-activated receptor PAR4 (ZCHEMR2)' [patent_app_type] => 1 [patent_app_number] => 9/053866 [patent_app_country] => US [patent_app_date] => 1998-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21480 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/111/06111075.pdf [firstpage_image] =>[orig_patent_app_number] => 053866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550422 [patent_doc_number] => 06346605 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Signal transducer for the TNF receptor super family, and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/052089 [patent_app_country] => US [patent_app_date] => 1998-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 16718 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346605.pdf [firstpage_image] =>[orig_patent_app_number] => 09052089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4247998 [patent_doc_number] => 06207391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'High-throughput screening assays for modulators of STAT4 and STAT6 activity' [patent_app_type] => 1 [patent_app_number] => 9/053003 [patent_app_country] => US [patent_app_date] => 1998-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14189 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207391.pdf [firstpage_image] =>[orig_patent_app_number] => 053003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353272 [patent_doc_number] => 06200775 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor' [patent_app_type] => 1 [patent_app_number] => 9/044404 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11970 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200775.pdf [firstpage_image] =>[orig_patent_app_number] => 044404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4351935 [patent_doc_number] => 06218128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities' [patent_app_type] => 1 [patent_app_number] => 9/042943 [patent_app_country] => US [patent_app_date] => 1998-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 30 [patent_no_of_words] => 78395 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218128.pdf [firstpage_image] =>[orig_patent_app_number] => 042943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4106313 [patent_doc_number] => 06057128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'MU-1, member of the cytokine receptor family' [patent_app_type] => 1 [patent_app_number] => 9/040005 [patent_app_country] => US [patent_app_date] => 1998-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9856 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057128.pdf [firstpage_image] =>[orig_patent_app_number] => 040005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4357092 [patent_doc_number] => 06255089 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Constitutively activated serotonin receptors' [patent_app_type] => 1 [patent_app_number] => 9/032742 [patent_app_country] => US [patent_app_date] => 1998-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 58 [patent_no_of_words] => 21994 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255089.pdf [firstpage_image] =>[orig_patent_app_number] => 032742 [rel_patent_id] =>[rel_patent_doc_number] =>)